How much does a box of evantumumab cost in 2024?

Amivantamab (amivantamab-vmjw) is a drug targeting non-small cell lung cancer (NSCLC). Its unique bispecific antibody structure makes it a target for the treatment of this disease. The drug, which comes as an injection and is given intravenously, helps the patient's immune system slow or stop the growth of cancer cells. Evantumumab is an important treatment option for patients with non-small cell lung cancer that has spread to other parts of the body or cannot be removed by surgery and that worsens during or after treatment with platinum chemotherapy drugs.

However, the price of this drug is relatively high. At present, the manufacturer of the generic drug Evantum is JANSSEN BIOTECH (Johnson & Johnson), which is mainly sold in some overseas countries such as the United States, the European Union and other places. Its specification is 350mg European version of the original drug, and the price of each box may be around 20,000 yuan. This price can be a significant burden for many patients, especially considering that treatment may need to continue for a period of time.

In addition, there are certain difficulties in purchasing evantumumab. Many patients may not have easy access to the drug due to restrictions on its overseas sales and high price. At the same time, there are currently no regions overseas that produce generic drugs of evantumumab, which further increases the difficulty for patients to obtain the drug.

In short, evantumumab injection, as an innovative drug, has important therapeutic significance for some patients with non-small cell lung cancer. However, its price is high and its purchase is relatively difficult. When patients decide to receive treatment with this drug, they should discuss and evaluate it with their doctor to understand its efficacy, side effects, cost, etc. to make a decision.